Paribello Carlo

Pilot Trial of Minocycline in Fragile X

FRAXA Research Foundation 2006-2010 Grants • Clinical • Paribello Carlo • Research Grant with Results • Surrey Place Centre Toronto July 9, 2008March 21, 2019autism, Fragile X Research Foundation of Canada, matrix metalloproteinase, mGluR5, minocycline, MMP9

With a $40,000 grant from FRAXA, Dr. Carlo Paribello and his team at the Surrey Place Centre Fragile X clinic in Toronto, Ontario, ran an open label trial to see if minocycline can improve learning and reduce anxiety and behavioral problems in people with Fragile X. Twenty participants between the ages of 13 and 35 years take minocycline for two months.